The Insider Selling: Healthequity Inc (HQY) Vice Chairman Sells $70,432.00 in Stock

The Insider Selling: Healthequity Inc (HQY) Vice Chairman Sells $70,432.00 in Stock

Healthequity Inc (NASDAQ:HQY) Vice Chairman Stephen Neeleman sold 1,600 shares of the firm’s stock in a transaction dated Tuesday, February 28th. The stock was sold at an average price of $44.02, for a total value of $70,432.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Stephen Neeleman also recently made the following trade(s):

Shares of Healthequity Inc (NASDAQ:HQY) opened at 43.54 on Monday. The company has a market capitalization of $2.58 billion, a PE ratio of 103.67 and a beta of 1.94. Healthequity Inc has a 52-week low of $21.42 and a 52-week high of $49.25. The firm’s 50-day moving average price is $45.21 and its 200 day moving average price is $39.33.

Healthequity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, December 6th. The company reported $0.10 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.09 by $0.01. Healthequity had a net margin of 15.19% and a return on equity of 11.08%. The company had revenue of $43.36 million for the quarter, compared to analyst estimates of $43.29 million. During the same period in the prior year, the company posted $0.08 EPS. The firm’s revenue for the quarter was up 41.9% on a year-over-year basis. On average, equities analysts forecast that Healthequity Inc will post $0.42 earnings per share for the current year.

Several analysts have weighed in on the company. Zacks Investment Research cut Healthequity from a “hold” rating to a “sell” rating in a research report on Monday, February 13th. KeyCorp assumed coverage on Healthequity in a research report on Monday, January 23rd. They set an “overweight” rating and a $60.00 price objective on the stock. Finally, Chardan Capital reaffirmed a “buy” rating and set a $47.00 price objective on shares of Healthequity in a research report on Tuesday, February 7th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Healthequity has a consensus rating of “Buy” and a consensus target price of $40.20.

Hedge funds have recently bought and sold shares of the company. O Shaughnessy Asset Management LLC acquired a new stake in Healthequity during the fourth quarter worth approximately $108,000. Sowell Financial Services LLC acquired a new stake in Healthequity during the fourth quarter worth approximately $203,000. SG Americas Securities LLC acquired a new stake in Healthequity during the third quarter worth approximately $220,000. Aperio Group LLC acquired a new stake in Healthequity during the third quarter worth approximately $227,000. Finally, Mark Sheptoff Financial Planning LLC acquired a new stake in Healthequity during the third quarter worth approximately $231,000. 89.22% of the stock is currently owned by institutional investors.

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Related posts

Leave a Comment